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Background: We characterise the loss to follow-up (locally termed abandoned) of tuberculosis treatment with
individual and ecological health determinants and to identify the predictive capacity of these risk factors.
Methods: A cohort study with individual and ecological characterisation of patients diagnosed with tuberculosis in
Sergipe/Brazil from 2015 to 2018 with either loss to follow-up or completion of treatment as a therapeutic
outcome was performed. The examined variables were based on the social determinants of health with descriptive
analysis, binary logistic regression, a generalised hierarchical model and graphical presentation using a
nomogram.
Results: The loss to follow-up accounted for 18.21% of the 2,449 studied cases. The characteristics revealed that
the highest abandonment percentages were people who: were male (20.0%), had black skin colour (20.3%), were
aged 20–39 years (21.8%), had 4–7 years of schooling (23.6%), re-entered treatment after abandonment (36.5%),
used alcohol (31.0%), used drugs (39.3%), were smokers (26.5%) and were homeless (55.4%). The ecological
characteristics showed that individuals living in municipalities with a high human development index (HDI; odds
ratio [OR]: 1.91) and high-income inequality (OR: 1.81) had a greater chance of not finishing the treatment. Most
of these variables were identified as predictors in the generalised hierarchical model; the receiver operating
characteristic curve (ROC) curve had 0.771 precision and 84.0% accuracy.
Conclusion: The group of identified characteristics influenced the loss to follow-up of tuberculosis treatment. This
data provides evidence for the early identification of individuals who are at greater risk of abandoning tuber-
culosis treatment.1. Introduction
Tuberculosis (TB) has a worldwide impact on public health, since it is
the infectious disease that kills the most people globally [1] and is an
epidemic still neglected [2] and not solved in the 21st century. The
severity of the epidemic is highly variable between countries, and the
World Health Organization (WHO) reinforces the implementation of
strategies and actions towards the end of the epidemic by 2030,
considering the pillars of early diagnosis, treatment and completion of
treatment [1].
TB treatment lasts for at least 6 months, so it is essential that the
professional guides the patient through the health service from diagnosis
to completion of treatment. Worldwide, out of the 30 priority countriesV.M.A. Lima).
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evier Ltd. This is an open accessfor TB control actions, only nine achieved a 90% treatment success rate.
Countries such as Angola, Brazil, the Central African Republic, Liberia
and Papua New Guinea showed greater than 10% loss following treat-
ment [1, 3]. In general, treatment success has increased, but loss to
follow-up remains high in the Americas (26%). Brazil has abandonment
rates from 38% [4] to 42% [5], which are considered high compared to
what is proposed by the WHO (<5%; 1,6).
The loss to follow-up in treatment can increase the transmissibility of
the disease. Therefore, TB completion of treatment is extremely impor-
tant for both the patient and the community in which s/he lives [6]. The
loss to follow-up is considered when an individual who after starting
treatment stops going to the health service for more than thirty consec-
utive days after the date scheduled for her/his return [3]. Understanding021
article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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reflects the connection of the social context with the biological aspect of
the disease and its transmissibility [7]. The loss to follow-up in treatment
is considered one of the main obstacles and challenges in the fight against
TB, and it has direct consequences on fast transmission of the disease,
elevated treatment cost, mortality and increased recurrence rates [8].
The analysed region in this study (Sergipe) has the highest percentage of
abandonment in the Brazilian Northeast [9].
The failures in global TB control have contributed to increased loss to
follow-up, mortality and drug resistance [10]. TB treatment loss to
follow-up is still prevalent on the world stage and is a serious problem for
global public health [11]. Thus, the Sustainable Development Goals
(SDG) ratify the need for improvements in the coverage of health services
and strategies that include socioeconomic determinants [1, 12].
When we consider the TB therapeutic process, we understand that
disease morbidity and mortality can be a reflection of the living condi-
tions of the population associated with individual factors and health
service quality. The reflection of these dynamics is important to establish
and recognise relationships between risk factors and the TB therapeutic
outcome. Therefore, the interaction of these characteristics can be un-
derstood in a broader sense and not only by individual-level factors.
The completion of treatment for TB requires specific monitoring by
health services in order to avoid therapeutic failures. In this sense, it is
crucial to understand themain factors that can influence treatment loss to
follow-up. Thus, this study aimed to characterise the loss to follow-up of
TB treatment using individual and ecological health determinants and to
identify the predictive capacity of these risk factors.
2. Methods
2.1. Study design
This cohort study utilised ecological and individual characterisation
of patients diagnosed with TB in Sergipe, Brazil from 2015 to 2018whose
therapeutic outcome was completion of treatment or loss to follow-up.
The other therapeutic outcomes, such as deaths (n ¼ 51), transfers (n
¼ 48), diagnostic change (n ¼ 23), cases still in treatment (n ¼ 17) and
drug-resistant TB (n¼ 6), were excluded from the analysis. Sergipe is one
of the 27 units of the Federative Republic of Brazil; it is the smallest of the
Brazilian states, occupying a total area of 21.910 km2. The population in
2018 was estimated at 2,278,308 inhabitants, with a population density
of 94.3 inhabitants/km2. It has 75 municipalities, and Aracaju is the state
capital [13]. It is situated in the Northeast Region and is bordered to the
north by the state of Alagoas and the S~ao Francisco River. To the south
and west, it is bordered by the state of Bahia and to the east by the
Atlantic Ocean [14].
2.2. Data source and definition of variables
The research used two data sources. Individual data were extracted
from the Information System of Notification Diseases (SINAN) provided
by the State Health Department of Sergipe. The ecological data were
supported by the Brazilian Institute of Geography and Statistics (IBGE),
referring to the 2010 census.
Individual characterisation of the cases diagnosed with TB was
explored by variables contained in SINAN, namely: sex (male or female);
skin colour (white, black, Asian, brown, indigenous or ignored); age
group (0–19, 20–39, 40–59 or 60 years and over); education in years
(unknown, 1–3, 4–7, 8–11 or 12 and more); area of residence (urban or
rural); case type, considering the existence of previous treatment (new
case, relapse, re-entry after loss to follow-up or transfer); form of TB
(pulmonary or extrapulmonary); AIDS (yes or no); alcohol use (yes or
no); diabetes (yes or no); mental disorder (yes or no); drug use (yes or
no); smoking (yes or no); deprived of liberty (yes or no); homeless (yes or
no); immigrant (yes or no); and recipient of government income (yes or
no).2
Considering the specific TB context, for ecological and contextual
characterisation two social indexes that represent world parameters were
used: the human development index (HDI), denoted as very high, high,
medium or low levels composed of the dimensions of education,
longevity and income of individuals [15], and the Gini index as a mea-
sure of income inequality between 0 (zero), representing complete
equality, and 1 (one), which represents complete inequality with cate-
gories defined in low, moderate and high inequality [16].
Hierarchical definition of the variables was based on the theoretical
model proposed by Dahlgren and Whitehead [17] and Solar and Irwin
[18]. The criteria of choice were based on the social determinants of
health (SDH) that show different levels of comprehensiveness, starting
with individual determinants (in a more proximal layer) to collective
determinants of society as a more distal layer (Figure 1). These conditions
highlight the possible influence of social determinants on health condi-
tions [19], specifically TB for this study.
The dependent dichotomic variable was the outcome of the case
diagnosed with TB: completion of treatment or loss to follow-up.2.3. Data analysis and ethical aspects
The statistical treatment of data reflects two approaches, namely in-
dividual and ecological. The data was initially stored in Microsoft Excel
(Windows version 2013, Microsoft Corporation; Redmond, WA, USA).
Analyses were performed using Statistical Package for the Social Sciences
version 24.0 (SPSS Inc., Chicago, IL, USA) or R version 3.6.0 (Copyright
2019, The R Foundation for Statistical Computing General Public
License).
Initially, individual and ecological descriptive analyses were shown
in absolute numbers and simple frequencies considering TB case outcome
(completion of treatment or loss to follow-up). We performed a bivariate
logistic regression for each individual and context variable in order to
determine the Beta (B) odds ratio (OR) and its respective 95% confidence
interval (CI), which means the estimated regression coefficient and the
respective statistics, derived from the logistic regression model that
predicts the dependent variable from the constant and the independent
variables. The logistic regression equation allowed estimating the prob-
ability of each individual belonging to a certain group (loss to follow-up
or completion of treatment).
To construct the hierarchical multiple model, the individual and
ecological variables that showed statistical significance with an error
probability less than 5% in the bivariate logistic regression were
considered. The generalised hierarchical model was applied [20], and
the codes for each municipality with reference to each TB case were used
as the basic structure for the model. The fixed effects were represented by
the independent variables at their individual and ecological levels, and
the random effect was at the municipal level.
We used the backward method considering the predictive capacity of
the significant variables and utilised the receiver operating characteristic
“Receiver Operating Characteristic” (ROC) curve to measure the sensitivity
and accuracy of the model. This method identified the determinant fac-
tors for TB treatment loss to follow-up with the construction of a risk
model. The choice of the best statistical performance was selected, the
logistic model that presented the best mathematical behavior, consid-
ering the performance and the area of the curve ROC in multi level
model.
The graphical representation of the predictive model is presented
using a nomogram that favours early identification of individuals at risk
for treatment loss to follow-up and provides good conditions for use in
health services. The nomogram contains a set of scales: one for each
variable identified in the predictive model, two for the calculation of the
score and one end that allows visualising the probability of abandonment
[6, 21, 22, 23]. The output of scale third, should be interpreted in
multiplication the number 0.1 to 0.9 for percentage risk of loss to
follow-up from 10% to 90%.
Figure 1. Hierarchical structure considering individuals and groups aligned at different levels.
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order to analyze the risk that the patient may have for loss of follow-up in
the treatment of tuberculosis. The nomogram is indicating the proba-
bility of loss to follow-up in association with the person's risk factors. This
risk is analyzed based on the risk factors of each individual and the sum
of these factors may result in a greater or lesser risk of loss to follow-up.
Health professionals should use the nomogram as follows: in a hy-
pothetical situation the patient has been diagnosed with TB and the
nomogramwill be applied to check the likelihood of loss to TB follow-up.
Example: Individual characteristics (first scale): black skin colour ¼
20 points; 30–39 years old ¼ 40 points; 1 to 3 education years ¼ 100
points; AIDS (No) ¼ 0 points; Alcohol use (Yes) ¼ 20 points; Drugs use
(No) ¼ 0 points; residence in urban area ¼ 20 points; Homeless (No) ¼
0 points; Re-entry after abandonment ¼ 87 points; Resides in an area
with a high HDI ¼ 20 points; Resides in an area with a high Gini Index ¼
0 points. Total (second scale): 307 points. To interpret the nomogram
(third scale), this hypothetical patient has between 0.6 and 0.7 chance of
abandonment, that is, a 60%–70% probability of losing TB follow-up.
Regarding ethical aspects, the rules described by Resolution 510/
2016 of the National Health Council were respected, and the research
was approved by the Ethics and Research Committee on Human (No.
1,768,049). The rules of the Helsinki Convention were followed.
3. Results
The descriptive analysis was supported by 2,449 TB occurrences with
therapeutic outcome of loss to follow-up or completion of treatment.
However, 51 people who died, 48 transfers to another state, 23 diag-
nostic change, 17 cases still in treatment and 6 people with drug resistant
TB were excluded from the analysis. The loss to follow-up represented3
18.21% of the analysed cases. Table 1 shows that loss to follow-up was
prevalent among males (20.03%), individuals with black (20.34%) and
brown (19.55%) skin colour, those aged 20 39 years (21.87%) and per-
sons with none or only a few years of education. Individuals who resided
in urban areas (19.64%), those who restarted treatment after loss to
follow-up (58.13%) and those diagnosed with pulmonary TB (19.08%)
had high abandonment rates. People with AIDS (42.33%), a mental
disorder (36.82%) and behavioural characteristics such as alcohol use
(31.05%) drug use (39.39%) or smoking (26.54%) were identified with
higher rates of neglect (Table 1).
Bivariate logistic regression revealed that the individuals who were
male, had brown skin colour, were aged 20–39 years old, had no or only a
few years of schooling, were urban dwellers or homeless, were diagnosed
with pulmonary TB, re-entered after treatment drop out, had AIDS or
mental disorder, used alcohol or illicit drugs and/or smoked were more
likely to abandon treatment (Table 2).
When considering the ecological characteristics, people who lived in
municipalities with a high HDI were 1.91 times more likely to give up
treatment when compared to those living in municipalities with a lower
HDI. Regarding the Gini index, people living in municipalities with
higher income inequality were 1.81 times more likely to abandon TB
treatment than those who lived in municipalities with lower income
inequality (Table 2).
Table 3 demonstrates the model with the best performance that
identified 11 statistically significant variables predictive of TB treatment
loss to follow-up. Predictive factors of the model included sociodemo-
graphic characteristics (skin colour, age group and schooling), existing
comorbidity (AIDS), behavioural characteristics (alcohol and drug use),
epidemiology (case type), living conditions (area of residence or
homeless) and social context (HDI and Gini). For the parameters and
Table 1. Descriptive analysis of sociodemographic, epidemiological and social context characteristics among those diagnosed with TB, considering an outcome of
completion of treatment or loss to follow-up, between 2015 and 2018 in Sergipe, Brazil.






















































































High inequality 669/75.71 215/24.36
Middle inequality 55/91.77 5/8.32
Low inequality 1279/85.03 226/15.04
*n/** Percentage of missing value.
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was 0.771 (p < 0.001; 95% CI: 0.741–0.802) and the accuracy was
84.0%.
The nomogram was constructed based on the predictive variables of
the generalised hierarchical model (Figure 2). The graph objectively
shows the risk variables for TB treatment loss to follow-up.4
4. Discussion
In our sample, TB treatment loss to follow-up was 18.21%, a value
much higher than theWHO's proposal, which recommends abandonment
of less than 5% [3, 24]. The predictive model identified that de-
mographic, behavioural and epidemiological characteristics, existing
Table 2. Bivariate logistic analysis of individual variables and social context among those diagnosed with TB who abandoned treatment between 2015 and 2018 in
Sergipe, Brazil.
Independent Variables Ba ORb p-value CIc 95%
Sex
2449* (0.0%)**




Black 0.683 1.979 0.002 1.290–3.038
Asian 0.526 1.693 0.311 0.611–4.689
Brown 0.632 1.882 <0.001 1.335–2.654




0–19 0.765 2.148 0.015 1.162–3.971
20–39 1.328 3.773 <0.001 2.351–6.053
40–59 1.054 2.868 <0.001 1.746–4.712
60 or more(ref) <0.001
Education in years
2019* (17.6%)**
Unknown 1.860 6.426 0.003 1.880–21.971
1–3 2.167 8.729 <0.001 2.723–27.976
4–7 2.311 10.087 <0.001 3.158–32.224
'8 a 11 1.493 4.450 0.014 1.359–14.573
12 or more(ref) <0.001
Residence
2346* (4.2%)**




Relapse 0.312 1.366 0.154 0.890–2.097
Re-entry after loss to follow-up 2.117 8.308 <0.001 6.052–11.404




























Yes 0.663 1.941 <0.001 1.548–2.435
No(ref)
Population deprived of liberty
2436* (0.5%)**













No 0.402 1.494 0.070 0.968–2.307
Human development index
2449*(0.0%)**




High inequality 0.598 1.819 <0.001 1.476–2.241
Middle inequality -0.665 0.514 0.160 0.204–1.299
Low inequality(ref) <0.001
*n/** Percentage of missing value/a beta/b Odds ratio/c Confidence Interval/(ref): reference.
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follow-up. The constructed nomogram allows the identification of pa-
tients at increased risk for loss to follow-up. In the multivariate context,
individuals with black (OR: 1.52) or brown skin (OR: 1.38), aged 20–39
years (OR: 2.34), without schooling (OR: 7.78) or with 4–7 years of
school (OR: 8.11) showed significant probabilities of not completing
treatment. These findings are in accordance with the literature [25, 26,
27].5
Individuals who acquire TB and already had AIDS as a comorbidity
were 2.61 times more likely to abandon TB treatment compared to those
who did not. Comorbidities may directly influence the TB therapeutic
outcome, and people with immunosuppressive diseases are historically
more likely to become ill with TB, especially those infected with HIV [3].
In this context, the individuality of these subjects should be treated in a
special way by health professionals in order to minimise cases of loss to
follow-up.
Table 3. Generalised hierarchical linear model with individual and ecological variables among those diagnosed with TB, considering a therapeutic outcome of
completion of treatment or loss to follow-up, in Sergipe, Brazil.
Fixed Effects ORaa CIb 95% p- value Coefficient
Intercept 0.004 (0.001–0.013) <0.001 -5.524
Level 1 (Individual Characteristics)
Skin Color
Black 1.522 (1.016–2.282) 0.042 0.420
Asian 1.023 (0.411–2.549) 0.960 0.023
Brown 1.386 (1.032–1.862) 0.030 0.327
Indigenous 3.031 (0.571–16.094) 0.193 1.109
White(ref)
Age group (years)
0–19 2.029 (1.110–3.709) 0.022 0.707
20–39 2.340 (1.398–3.916) <0.001 0.850
40–59 1.482 (0.835–2.629) 0.179 0.393
60 or more(ref)
Education in years
Unknown 7.780 (2.666–22.704) <0.001 2.052
1–3 7.610 (2.764–20.957) <0.001 2.030
4–7 8.116 (3.539–18.611) <0.001 2.094
8 a 11 5.055 (2.328–10.976) <0.001 1.620
12 or more(ref)
AIDS
Yes 2.617 (1.309–5.232) 0.007 0.962
No(ref)
Alcohol
Yes 1.608 (1.001–2.584) 0.049 0.475
No(ref)
Drugs use
Yes 1.645 (1.145–2.363) 0.007 0.498
No(ref)
Residence
Urban 1.583 (1.092–2.297) 0.015 0.460
Rural(ref)
Homeless
Yes 2.443 (1.464–4.074) <0.001 0.893
No(ref)
Case type
Relapse 0.949 (0.535–1.683) 0.857 -0.052
Re-entry after loss to follow-up 5.751 (4.322–7.652) <0.001 1.749
Transfer 2.310 (1.145–4.659) 0.019 0.837
New(ref)
Level 2 (Characteristics of Context Social)
Human development index
High 1.591 (1.345–1.881) <0.001 0.464
Middle(ref)
Gini index
High inequality 0.792 (0.619–1.013) 0.063 -0.233
Middle inequality 0.860 (0.378–1.954) 0.718 -0.151
Low inequality(ref)
a Odds Ratio Adjusted/b Confidence Interval/(ref): reference.
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may compromise treatment success. Our study corroborates the
literature [6] that identifies the use of alcohol and illicit drugs in-
dicates a greater probability of loss to follow-up compared to those
who do not use them. A study developed in Russia ratifies the
importance of this group when it identified that interventions to
reduce alcohol consumption associated with nutritional support and
involving the patient with her/his disease improves adherence to TB
treatment [28].6
Homeless patients were 2.44 times more likely to abandon TB treat-
ment when compared to those living in a household. A previous study
identified that homeless individuals are 56 times more likely to become
ill with TB [3]. The literature states that the health conditions of pop-
ulations are directly related to the context in which they live and the
position of individuals in the social pyramid [29]. Homeless patients
are not a new phenomenon and this reality demands changes [30].
Therefore, the impact of social determinants on maintaining TB trans-
mission is crucially important [31].
Figure 2. Nomogram with risk factors for tuberculosis treatment loss to follow-up in Brazil.
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highlighted worldwide [11] and they are not different from the Bra-
zilian reality. Indeed, we identified that individuals living in a mu-
nicipality with a high HDI were 1.91 times more likely to not finish TB
treatment when compared to municipalities with a lower HDI. This fact
can be explained by the accelerated urbanisation of large cities.
Further, although cities have high levels of development in education,
longevity and income, there is a large discrepancy between living
conditions. The association of the high HDI with loss to follow-up also
can be justified because cities with a high human development index
also contain large pockets of poverty and persistent peripheral areas.
Thus, these situations of high percentages in the loss to follow-up can
be blindfolded and covered up by major economic development within
cities and states.
Income inequality, expressed by the Gini index, explains this reality
when it revealed that people living in municipalities with high income
inequality were 1.8 times more likely to TB treatment loss to follow-up.
In Brazil, the greatest social inequality is driven by income disparity
with a wide heterogeneous distribution in the population, a fact that
significantly impacts adherence to treatment and mortality from TB
[32]. Thus, although a municipality may have a high HDI, it may also
show great inequalities among its populations, a phenomenon that in-
dicates risks for not completing TB treatment. Thus, policy strategies to
cover health services that are in line with the social and economic
development of cities may reduce known risk factors for TB treatment
loss to follow-up.
TB surveillance based on territory [33] and literature that
approach the relations of the individual and family with the social
environment, such as the genogram and ecomap [34], stimulate
pathways of success in the therapeutic process. We emphasise that at
the national level, potential implementation of this clinical practice
with the use of risk nomograms is an innovative and stimulating
proposal for the development of the present study. Other researchers
have also developed similar models to predict better TB treatment
outcomes [21, 23, 35].
The study has some limitations. Although the utilised data were
collected by the national surveillance service of transmissible diseases in7
Brazil, many variables with missing values were found. However, the
data analysis was not compromised by this issue due to the importance of
the theme worldwide and the magnitude of the sample under analysis.
These factors allow the results to be amplified.
5. Conclusion
This study identified individual and ecological risk factors for aban-
doning TB treatment in patients in Sergipe, Brazil. The data revealed that
individuals who are male, have brown or black skin, aged 20–39 years,
have little schooling, live with AIDS, use alcohol and drugs, live in urban
areas, are homeless or live in municipalities with high a HDI and high-
income inequality are more likely to not adhere to TB treatment. The
nomogram provides health professionals with an early identification of
individuals who are at risk for treatment loss to follow-up.
Individuals with more risk factors should be viewed as more
vulnerable populations; they would require differentiated treatment
completion of treatment strategies. The health service and social condi-
tions must guide the synergy of this movement to achieve different and
better results. Therefore, it is necessary to monitor the individuals in a
specific way with a balanced orientation and without risks to the
completion of treatment process. We reinforce that the greatest capacity
in the diagnosis and treatment service must be located where the need of
the individual, family and community is greatest.
The social inequities, behavioral and epidemiological characteristics
and existing comorbidities influence loss to follow-up. The completion of
treatment for TB requires specific monitoring by health services and the
identification of patients at increased risk for loss to follow-up is essential
to improve health care and control of TB.
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